PDCD1 and classic Hodgkin lymphoma: Despite the initial sensitivity to PD-1 blockade, most patients eventually experience a relapse despite the persistence of these same tumor-intrinsic abnormalities suggesting alternate mechanisms exist that contribute to the development of the permissive TME in cHL.